Journal
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
Volume 26, Issue 11, Pages 2462-2468Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/01.ATV.0000242013.29441.81
Keywords
soluble expoxide hydrolase; epoxyeicosatrienoic acids; PPAR alpha; smooth muscle cells; proliferation
Categories
Funding
- NHLBI NIH HHS [R01 HL053994, R01 HL59699-06A1, R01 HL059699, R01 HL53994] Funding Source: Medline
- NIEHS NIH HHS [R37 ES02710, R37 ES002710, P30 ES05707, P30 ES005707, P42 ES04699, P42 ES004699] Funding Source: Medline
- NIGMS NIH HHS [R01 GM031278, R01 GM31278] Funding Source: Medline
Ask authors/readers for more resources
Objective - Proliferation of smooth muscle cells is implicated in cardiovascular complications. Previously, a urea- based soluble epoxide hydrolase inhibitor was shown to attenuate smooth muscle cell proliferation. We examined the possibility that urea- based alkanoic acids activate the nuclear receptor peroxisome proliferator-activated receptor alpha ( PPAR alpha) and the role of PPAR alpha in smooth muscle cell proliferation. Methods and Results - Alkanoic acids transactivated PPAR alpha, induced binding of PPAR alpha to its response element, and significantly induced the expression of PPAR alpha- responsive genes, showing their function as PPAR alpha agonists. Furthermore, the alkanoic acids attenuated platelet- derived growth factor - induced smooth muscle cell proliferation via repression of cyclin D1 expression. Using small interfering RNA to decrease endogenous PPAR alpha expression, it was determined that PPAR alpha was partially involved in the cyclin D1 repression. The antiproliferative effects of alkanoic acids may also be attributed to their inhibitory effects on soluble epoxide hydrolase, because epoxyeicosatrienoic acids alone inhibited smooth muscle cell proliferation. Conclusions - These results show that attenuation of smooth muscle cell proliferation by urea- based alkanoic acids is mediated, in part, by the activation of PPAR alpha. These acids may be useful for designing therapeutics to treat diseases characterized by excessive smooth muscle cell proliferation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available